144 related articles for article (PubMed ID: 7408396)
1. Thiol S-methylation in uremia: erythrocyte enzyme activities and plasma inhibitors.
Pazmiño PA; Sladek SL; Weinshilboum RM
Clin Pharmacol Ther; 1980 Sep; 28(3):356-67. PubMed ID: 7408396
[TBL] [Abstract][Full Text] [Related]
2. Methyl conjugation in uraemia: catechol-O-methyltransferase.
Pazmiño PA; Weinshilboum RM
Br J Clin Pharmacol; 1980 Nov; 10(5):509-18. PubMed ID: 7437264
[TBL] [Abstract][Full Text] [Related]
3. Human pharmacogenetics of methyl conjugation.
Weinshilboum RM
Fed Proc; 1984 May; 43(8):2303-7. PubMed ID: 6714437
[TBL] [Abstract][Full Text] [Related]
4. Human thiopurine S-methyltransferase activity in uremia and after renal transplantation.
Weyer N; Kröplin T; Fricke L; Iven H
Eur J Clin Pharmacol; 2001 May; 57(2):129-36. PubMed ID: 11417444
[TBL] [Abstract][Full Text] [Related]
5. Methylation pharmacogenetics: thiopurine methyltransferase as a model system.
Weinshilboum RM
Xenobiotica; 1992; 22(9-10):1055-71. PubMed ID: 1441597
[TBL] [Abstract][Full Text] [Related]
6. Efficient screening method of the thiopurine methyltransferase polymorphisms for patients considering taking thiopurine drugs in a Chinese Han population in Henan Province (central China).
Zhang LR; Song DK; Zhang W; Zhao J; Jia LJ; Xing DL
Clin Chim Acta; 2007 Feb; 376(1-2):45-51. PubMed ID: 16952345
[TBL] [Abstract][Full Text] [Related]
7. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.
Weinshilboum RM; Sladek SL
Am J Hum Genet; 1980 Sep; 32(5):651-62. PubMed ID: 7191632
[TBL] [Abstract][Full Text] [Related]
8. Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations.
Lennard L; Van Loon JA; Lilleyman JS; Weinshilboum RM
Clin Pharmacol Ther; 1987 Jan; 41(1):18-25. PubMed ID: 3467886
[TBL] [Abstract][Full Text] [Related]
9. Diethyldithiocarbamate S-methylation: evidence for catalysis by human liver thiol methyltransferase and thiopurine methyltransferase.
Glauser TA; Nelson AN; Zembower DE; Lipsky JJ; Weinshilboum RM
J Pharmacol Exp Ther; 1993 Jul; 266(1):23-32. PubMed ID: 8392551
[TBL] [Abstract][Full Text] [Related]
10. Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties.
Weinshilboum RM; Raymond FA; Pazmiño PA
Clin Chim Acta; 1978 May; 85(3):323-33. PubMed ID: 657528
[TBL] [Abstract][Full Text] [Related]
11. Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes.
Szumlanski CL; Honchel R; Scott MC; Weinshilboum RM
Pharmacogenetics; 1992 Aug; 2(4):148-59. PubMed ID: 1306116
[TBL] [Abstract][Full Text] [Related]
12. Thiol methylation pharmacogenetics: heritability of human erythrocyte thiol methyltransferase activity.
Keith RA; Van Loon J; Wussow LF; Weinshilboum RM
Clin Pharmacol Ther; 1983 Oct; 34(4):521-8. PubMed ID: 6617076
[TBL] [Abstract][Full Text] [Related]
13. Thiopurine methyltransferase. Aromatic thiol substrates and inhibition by benzoic acid derivatives.
Woodson LC; Ames MM; Selassie CD; Hansch C; Weinshilboum RM
Mol Pharmacol; 1983 Nov; 24(3):471-8. PubMed ID: 6633508
[TBL] [Abstract][Full Text] [Related]
14. Variability in the rate of 6-mercaptopurine methylation in the erythrocytes, liver and kidney in an Italian population.
Ferroni MA; Marchi G; Sansone E; Romeo P; Giulianotti PC; Pietrabissa A; Mosca F; Pacifici GM
Eur J Clin Pharmacol; 1996; 51(1):23-9. PubMed ID: 8880047
[TBL] [Abstract][Full Text] [Related]
15. Erythrocyte fraction affects red blood cell thiopurine methyltransferase activity.
Klemetsdal B; Straume B; Lysaa R; Giverhaug T; Aarbakke J
Eur J Clin Pharmacol; 1995; 48(6):495-9. PubMed ID: 8582469
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human erythrocyte phenol-O-methyltransferase in uremia.
Pazminño P; Rogoff F; Weinshilboum R
Clin Pharmacol Ther; 1979 Oct; 26(4):464-72. PubMed ID: 487694
[No Abstract] [Full Text] [Related]
17. Identification of factors regulating thiopurine methyltransferase activity in a Norwegian population.
Klemetsdal B; Straume B; Wist E; Aarbakke J
Eur J Clin Pharmacol; 1993; 44(2):147-52. PubMed ID: 8453958
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of thiopurine S-methyltransferase activity by impurities in commercially available substrates: a factor for differing results of TPMT measurements.
Kröplin T; Fischer C; Iven H
Eur J Clin Pharmacol; 1999 Jun; 55(4):285-91. PubMed ID: 10424321
[TBL] [Abstract][Full Text] [Related]
19. Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia.
Chrzanowska M; Kuehn M; Januszkiewicz-Lewandowska D; Kurzawski M; Droździk M
Acta Pol Pharm; 2012; 69(3):405-10. PubMed ID: 22594254
[TBL] [Abstract][Full Text] [Related]
20. Thiopurine methyltransferase activity in a Korean population sample of children.
Park-Hah JO; Klemetsdal B; Lysaa R; Choi KH; Aarbakke J
Clin Pharmacol Ther; 1996 Jul; 60(1):68-74. PubMed ID: 8689814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
